-
Ferring’s European Marketing Authorisation Application for controlled release misoprostol vaginal delivery system for the induction of labour accepted for review
-Ferring Pharmaceuticals announced today that it has received confirmation from European health authorities that the Marketing Authorisation…
-
Ferring Announces FDA Acceptance of NDA Filing for Controlled Release Misoprostol Vaginal Insert for Decreasing Time to Vaginal Delivery in Women
-Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA)…
-
New study showed desmopressin melt reduced sleep disruption in bedwetting children
-Preliminary results from a new, prospective study presented today at the first Joint Congress of the International Children’s Continence…
-
Fonds de solidarité FTQ, CTI Life Sciences Fund and Ferring Pharmaceuticals Create a New Biotech in Québec
-The Fonds de solidarité FTQ (the “Fonds”), CTI Life Sciences Fund and Ferring Pharmaceuticals are pleased to announce…
-
FDA approves Ferring’s PREPOPIK™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) for colonoscopy prep
-The U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market PREPOPIK (sodium picosulfate, magnesium…
-
Ferring Pharmaceuticals Acquires Licensing Rights for Elobixibat from Albireo AB
-Ferring Pharmaceuticals (Ferring) and Albireo AB (Albireo) announced today that they have signed a license agreement under which Ferring has…
-
Ferring Pharmaceuticals donates $10 million to the Salk Institute for Biological Studies
-Ferring Pharmaceuticals, a global, specialty biopharmaceuticals company, has donated $10 million to support research at the Salk Institute…
-
New data show that FIRMAGON® (degarelix) is non-inferior to the combination of goserelin plus bicalutamide at reducing prostate volume in patients with advanced hormone-dependent prostate cancer while offering better relief from lower urinary tract symptoms
-Two new studies presented at the 27th Annual European Association of Urology (EAU) Congress reported that…
-
Ferring announces new million euro educational initiative with International Federation of Fertility Societies (IFFS) and Elsevier
-World leader in fertility treatments, Ferring Pharmaceuticals, announced today at the 2012 Updates in Infertility Treatment (UIT) meeting that…
PRESS RELEASE 2012
PRESS RELEASE 2012